Abbreviations used in this paper: ERAD, ER-associated degradation; ILD, interstitial lung disease; MFI, mean fluorescence intensity; MOI, multiplicity of infection; PI, propidium iodide; RSV, respiratory syncytial virus; SP-C, surfactant protein C; SR, super repressor; UPR, unfolded protein response.

Introduction
============

SP-C (surfactant protein C) is a transmembrane protein that is synthesized as a 191-- or 197--amino acid proprotein by type II epithelial cells of the lung. Processing of the proprotein in the distal secretory pathway liberates a 35--amino acid peptide that is secreted into the airspaces as a component of pulmonary surfactant. Mutations in the gene encoding SP-C (*SFTPC*) have been associated with the development of sporadic and familial interstitial lung disease (ILD). In all cases to date, the mutation was present on only one allele consistent with a dominant-negative effect. The index mutation, a heterozygous base substitution of A for G at the first base of intron 4 (c.460 + 1 G→A), led to the internal deletion of 37 amino acids from the ER luminal domain, generating a truncated proprotein (SP-C^Δexon4^; [@bib28]). Two separate *SFTPC* mutations associated with ILD, SP-C^L188Q^ and SP-C^I73T^, were detected in three kindreds ([@bib39]; [@bib3]; [@bib2]). The age of onset and penetrance of ILD varied markedly in all three kindreds.

Studies in transiently transfected cells suggested that the c.460 + 1 G→A mutation led to misfolding of the mutant proprotein, retention of SP-C^wt^ in the ER, activation of the unfolded protein response (UPR), and apoptosis ([@bib1]; [@bib45]; [@bib24]). SP-C^Δexon4^ was also associated with cytotoxicity and lung dysmorphogenesis when expressed in type II cells of transgenic mice ([@bib1]). The UPR is activated by conditions that perturb ER homeostasis, including the accumulation of misfolded proteins ([@bib35]). This response encompasses translational and transcriptional changes within the cell to alleviate the stress and to promote restoration of ER homeostasis. A model for the time-dependent induction of the UPR has been proposed, suggesting that translational repression via PERK activation/eIF2α phosphorylation occurs first followed by the cleavage of ATF6, activation of IRE1/XBP-1, and expression of ATF6 and XBP-1 target genes ([@bib47]). If ER homeostasis cannot be restored by these pathways or by the induction of adaptive responses, apoptosis may occur as a means of avoiding the untoward effects of cell necrosis. ER stress--induced apoptosis has been associated with induction of the transcription factor C/EBP homologous protein, activation of c-Jun amino-terminal kinase via IRE1, and activation of the ER stress--specific caspases 4 (human; [@bib13]) and 12 (mouse; [@bib25]; [@bib42]; [@bib12]; for review see [@bib31]). Although the effects of acute ER stress, which is imposed by xenotoxic agents such as thapsigargin and tunicamycin, are well established, little is known about the molecular pathways involved in adaptation to chronic ER stress imposed by a misfolded protein.

The variability in the age of onset and penetrance of disease in the SP-C^L188Q^ and SP-C^I73T^ pedigrees suggests that both genetic and environmental factors may influence the manifestation of lung disease. Based on the results of the aforementioned studies in human patients and transiently transfected cells, experiments were designed to test the hypotheses that (1) chronic ER stress imposed by misfolded SP-C promotes adaptation and cell survival and (2) adaptation increases susceptibility to environmental stress. Clonal cell lines stably expressing SP-C^Δexon4^ or SP-C^wt^ were generated to identify cytoprotective pathways that are associated with adaptation to the constitutive expression of misfolded SP-C and to assess the cytotoxic effects of environmental stress on adapted cells.

Results
=======

Generation and characterization of stably transfected cell lines
----------------------------------------------------------------

To determine the molecular mechanisms underlying SP-C^Δexon4^-induced cytotoxicity, HEK293 cell lines stably expressing SP-C^wt^ or SP-C^Δexon4^ were generated. Multiple clonal lines were obtained for each construct, and two lines were chosen for subsequent experimentation based on equivalent expression of SP-C mRNA, which was initially assessed by RT-PCR ([Table I](#tbl1){ref-type="table"}) and subsequently confirmed by microarray analysis ([Fig. 1 b](#fig1){ref-type="fig"}). These cell lines were morphologically indistinguishable by light microscopy ([Fig. 1 a](#fig1){ref-type="fig"}) or electron microscopy (not depicted) and exhibited similar doubling rates (not depicted). Basal SP-C protein levels were assessed by Western blot analysis of cell lysates with an antibody directed against the NH~2~-terminal peptide of the proprotein (proSP-C), a region which is unaffected by the Δexon4 mutation. Despite equivalent mRNA levels, expression of the SP-C^Δexon4^ protein was barely detectable compared with SP-C^wt^, which is consistent with rapid proteasome-dependent turnover of the mutant proprotein ([Fig. 1 c](#fig1){ref-type="fig"}).

###### 

**Transcriptional profiling reveals differential expression of genes associated with apoptosis in SP-C^Δexon4^ cells**

  -------------------------------------------------------------------------------------------------------------------------------------------------
  Fold change\   Fold change\      Gene      Description                         Function[a](#tblfn1){ref-type="table-fn"}   NF-κB--binding sites
  (microarray)   (real-time PCR)                                                                                             
  -------------- ----------------- --------- ----------------------------------- ------------------------------------------- ----------------------
  +4.8           +4.2              MYC       V-myc myelocytomatosis viral\       Regulation of apoptosis                     1
                                                 oncogene homologue (avian)                                                  

  +2.3           ND                SNCA      Synuclein, α                        Anti                                        1

  +2.1           ND                PROK2     Prokineticin 2                      Anti                                        1

  +1.7           +2.9              IKBKG     Inhibitor of κ-light polypeptide\   Pro                                         1
                                                 gene enhancer in B cells,\                                                  
                                                 kinase γ                                                                    

  +1.6           ND                PBEF      Pre--B cell colony--enhancing\      Anti                                        1
                                                 factor 1                                                                    

  +1.6           ND                BNIP1     Bcl2/adenovirus E1B 19-kD\          Anti and pro                                2
                                                 interacting protein 1                                                       

  +1.5           ND                MAPK14    Mitogen-activated protein\          Anti                                        2
                                                 kinase 14                                                                   

  +1.5           ND                MYB       V-myb myeloblastosis viral\         Regulation of apoptosis                     1
                                                 oncogene homologue (avian)                                                  

  +2.1           ND                PDCD8     Programmed cell death 8             Pro                                         0

  +2.0           ND                HRK       Harakiri, Bcl2-interacting\         Pro                                         0
                                                 protein                                                                     

  +1.8           ND                HTATIP2   HIV-1 Tat interactive protein 2     Anti                                        0

  +1.7           ND                BCAP31    B cell receptor--associated\        Apoptosis                                   0
                                                 protein 31                                                                  

  +1.6           ND                PLAGL1    Pleiomorphic adenoma\               Pro                                         0
                                                 genelike 1                                                                  

  +1.6           ND                BAX       Bcl2-associated X protein           Pro                                         0

  +1.6           ND                P8        P8 protein                          Pro                                         0

  +1.6           ND                BAG2      Bcl2-associated athanogene 2        Apoptosis                                   0

  +1.6           ND                MRPS30    Mitochondria ribosomal\             Apoptosis                                   0
                                                 protein S30                                                                 

  +1.5           ND                TNFRSF6   TNF receptor superfamily,\          Anti                                        0
                                                 member 6                                                                    

  −3.0           ND                SFRP1     Secreted frizzled rp1               Anti                                        2

  −3.0           ND                CD24      CD24 antigen                        Pro                                         1

  −2.1           ND                FLI1      Friend leukemia virus\              Cell death                                  1
                                                 integration 1                                                               

  −2.0           ND                RUNX3     Runt-related transcription\         Apoptosis                                   2
                                                 factor 3                                                                    

  −1.6           ND                PSEN1     Presenilin 1                        Anti                                        1

  −1.6           ND                CDC2L2    Cell division cycle 2--like 2       Apoptosis                                   1

  −1.6           −3.6              DUSP6     Dual specificity phosphatase 6      Apoptosis                                   1

  −3.0           ND                TGF-β1    Transforming growth factor β1       Anti                                        0

  −2.1           ND                Bcl2      B cell CLL/lymphoma 2               Anti                                        0

  −1.9           ND                PHLDA2    Pleckstrin homology-like DA2        Apoptosis                                   0

  −1.9           ND                AKT1      V-akt murine thymoma viral\         Anti                                        0
                                                 oncogene                                                                    

  −1.7           ND                TIA1      RNA-binding protein                 Apoptosis                                   0

  −1.8           ND                PTPN6     Protein tyrosine phosphatase N6     Apoptosis                                   0

  −1.7           ND                PRKCZ     Protein kinase C, ζ                 Anti                                        0

  −1.7           ND                MCL1      Bcl-2 related protein               Anti and pro                                0

  +1.7           +2.3              IRAK1     IL-1 receptor-associated kinase 1   NF-κB pathway                               0
  -------------------------------------------------------------------------------------------------------------------------------------------------

The clonal cell lines expressing SP-C^wt^, SP-C^Δexon4^, or empty vector were subjected to transcriptional profiling using the human U133 gene chip set from Affymetrix. Genes that were specifically increased or decreased in SP-C^Δexon4^ over both SP-C^wt^ and an empty vector control (i.e., mutant-specific changes) are reported as fold changes from microarray analysis (first column). Select targets were validated by real-time PCR (second column). The last column lists the number of putative NF-κB--binding sites located in the 5′ flanking sequence (1 kb) of the gene on the left. Data represent the mean of three analyses for each genotype.

Anti and pro designations signify anti- and pro-apoptosis; evidence of apoptosis is from the Gene Ontology database.

![**Generation of clonal stably transfected cell lines.** (a) Phase light micrographs of stably transfected HEK293 cell lines expressing SP-C^wt^ or SP-C^Δexon4^. (b) Expression of SP-C mRNA in the two cell lines. Error bars represent SD. (c) 30 μg of cell lysates were subjected to immunoblot analysis using antibody directed against the NH~2~ terminus of proSP-C to detect SP-C^wt^ (M~r~ = 21 k) and SP-C^Δexon4^ (M~r~ = 17 k). (d and e) Subcellular localization of SP-C^wt^ to lysosomes (d) and SP-C^Δexon4^ to ER (e) in clonal cell lines by confocal microscopy. Bars (a and d), 20 μm; (e) 10 μm.](jcb1720395f01){#fig1}

SP-C^Δexon4^ protein was previously shown to be rapidly degraded in a proteasome-dependent manner and failed to be exported from the ER when transiently expressed in HEK293 cells ([@bib1]). To determine the subcellular localization of the SP-C variants in stably transfected cell lines, cells were stained with antibodies directed against proSP-C and LAMP-1 and analyzed by confocal microscopy. A bright, punctuate staining pattern was observed for proSP-C in SP-C^wt^ cells, whereas cells expressing SP-C^Δexon4^ showed faint, diffuse staining that was detected only in the presence of proteasome inhibitor ([Fig. 1 d](#fig1){ref-type="fig"}). SP-C^wt^ traffics to the lamellar body in type II cells but is redirected to the lysosome in cells that lack lamellar bodies (for reviews see [@bib7]; [@bib46]). Colocalization of SP-C^wt^ with the lysosomal marker LAMP-1 demonstrated efficient export of wild-type protein from the ER ([Fig. 1 d](#fig1){ref-type="fig"}). In contrast, SP-C^Δexon4^ exhibited a faint and diffuse staining pattern that colocalized with an anti-KDEL antibody, an ER marker ([Fig. 1 e](#fig1){ref-type="fig"}). These data in clonal cell lines, coupled with previous results in transiently transfected cells ([@bib1]), suggest that SP-C^wt^ is correctly folded and exported from the ER, whereas SP-C^Δexon4^ fails quality control and is rapidly degraded by the proteasome.

Transcriptional profiling reveals differential expression of genes associated with apoptosis in SP-C^Δexon4^ cells
------------------------------------------------------------------------------------------------------------------

Molecular pathways induced by the chronic expression of SP-C^Δexon4^ were identified by transcriptional profiling of SP-C^wt^ and SP-C^Δexon4^ clonal cell lines (the complete dataset can be found at <http://www.ncbi.nlm.nih.gov/geo/>; GenBank/EMBL/DDBJ accession no. [GSE2980](GSE2980)). Unexpectedly, known components of the UPR/ER-associated degradation (ERAD) pathways were not increased in cells that constitutively expressed SP-C^Δexon4^, which is in contrast to results in transiently transfected cells ([@bib1]). However, several genes associated with anti- and pro-apoptosis pathways were differentially expressed in the SP-C^Δexon4^ clonal cell line, including BAX and Bcl-2 ([Table I](#tbl1){ref-type="table"}, Fig. S1, and Table S1; available at <http://www.jcb.org/cgi/content/full/jcb.200508016/DC1>). Interestingly, two transcripts linked to the NF-κB pathway, interleukin-1 receptor-associated 1 (IRAK1) and the γ subunit of the Iκ-B kinase complex (IKBKG), were increased in the SP-C^Δexon4^ cells, which is consistent with alterations in the NF-κB signaling pathway. Analyses of the 5′ flanking sequences of apoptosis-associated genes revealed that ∼44% (15/34) contained putative NF-κB binding sites, suggesting that they may be direct targets of NF-κB.

To determine whether NF-κB activity was increased in SP-C^Δexon4^ cells, an NF-κB luciferase reporter construct was transiently transfected into the clonal cell lines. SP-C^Δexon4^ cells exhibited an 8.6-fold increase in basal NF-κB activity compared with cells stably transfected with empty vector or SP-C^wt^ ([Fig. 2 a](#fig2){ref-type="fig"}). Cotransfection of a stabilized, nonphosphorylatable form of I-κBα (super repressor \[SR\]) with the NF-κB reporter resulted in a dose-dependent decrease in luciferase activity in SP-C^Δexon4^ cells that was completely suppressed to levels detected in untreated SP-C^wt^ cells ([Fig. 2 b](#fig2){ref-type="fig"}). IκBα protein in SP-C^Δexon4^ cells was decreased compared with SP-C^wt^ cells, which is consistent with increased NF-κB activity ([Fig. 2 c](#fig2){ref-type="fig"}). Treatment of SP-C^Δexon4^ cells with SN50 peptide to inhibit the nuclear translocation of NF-κB resulted in cellular retraction and a significant increase in cell death, as indicated by propidium iodide (PI) staining ([Fig. 3 a](#fig3){ref-type="fig"}) and MTS reduction assay ([Fig. 3 c](#fig3){ref-type="fig"}). Treatment of SP-C^Δexon4^ cells with a control peptide, SN50~mut~, at equivalent doses and duration had no effect ([Fig. 3 b](#fig3){ref-type="fig"}). Cells expressing SP-C^wt^ were unaffected by SN50 or SN50^mut^ treatment (not depicted). Treatment of SP-C^Δexon4^ cells with SN50 decreased basal NF-κB activity as measured by a NF-κB reporter ([Fig. 3 d](#fig3){ref-type="fig"}) and inhibited nuclear translocation of the p65 subunit of NF-κB ([Fig. 3 e](#fig3){ref-type="fig"}). Altogether, these results suggest that NF-κB, mediated in part by the p65 subunit, plays an important cytoprotective role in adaptation to the constitutive expression of SP-C^Δexon4^.

![**Basal NF-κB activity is increased in cells expressing SP-C^Δexon4^.** (a) The clonal cell lines expressing empty vector (EV), SP-C^wt^, or SP-C^Δexon4^ were transiently cotransfected with an NF-κB reporter construct (pELAM-Luc) and a plasmid encoding renilla luciferase (pRL-TK). Luciferase activity was read 48 h after transfection. Similar results were obtained with two additional NF-κB luciferase reporter constructs, including a minimal IL-8 promoter and a synthetic NF-κB promoter (not depicted). \*, P \< 0.05 compared with SP-C^wt^. (b) SP-C^wt^ (open bars) or SP-C^Δexon4^ (closed bars) clonal cell lines were transiently transfected with pELAM-Luc, pRL-TK, and increasing amounts (10 pg--1 ng) of a plasmid encoding a super repressor of NF-κB activity (SR). EV indicates 10 ng of empty vector control. Groups with 10 ng/ml TNFα were treated for 12 h. Luciferase activity was assessed 36 h after transfection. Results are presented as means ± SD (error bars) of the ratio of firefly/renilla, expressed as relative luciferase units; each determination was performed in triplicate, and the experiment was repeated four times. \*, P \< 0.05 compared with SP-C^Δexon4^ untreated; \#, P \< 0 .05 compared with SP-C^wt^ unRx. (c) Immunoblot analysis of whole cell lysates using antibody directed against IκBα (top) or actin (bottom). Cells were treated with 5 μm MG-132 for 4 h before harvest.](jcb1720395f02){#fig2}

![**Inhibition of NF-κB nuclear translocation induces death of SP-C^Δexon4^ cells.** (a and b) The clonal cell line expressing SP-C^Δexon4^ was treated with SN50, a cell-permeable peptide that inhibits the nuclear translocation of NF-κB (a), or a mutant SN50 peptide (SN50~mut~; b) at the indicated doses. Cells were stained with PI 24 h after the addition of peptide and phase (top), and fluorescent (bottom) images were captured directly from the culture plate. Bars, 50 μm. (c) Clonal cell lines expressing SP-C^wt^ or SP-C^Δexon4^ were treated with the SN50 peptide at indicated doses for 24 h, and cell death was quantitated by MTS assay. (d) The clonal cell line expressing SP-C^Δexon4^ was transiently cotransfected with the pELAM-Luc and pRL-TK vectors. Cells were treated with SN50 or SN50~mut~ peptide 24 h after transfection at indicated doses. SR was cotransfected with pELAM-Luc and pRL-TK as positive controls. Luciferase activity was assessed 48 h after transfection. Results in c and d are presented as means ± SD (error bars); each determination was performed in triplicate, and the experiment was repeated three times. \*, P \< 0.05 compared with SP-C^Δexon4^ unRx; \#, P \< 0.05 compared with SP-C^wt^ unRx. (e) Immunoblot analysis of nuclear extracts with an anti-p65 antibody (top) or histone H2B (bottom). SP-C^Δexon4^ cells were treated with 50 μg/ml SN50 or SN50~mut~ for 24 h before harvest. SP-C^wt^ cells were treated with 10 ng/ml TNFα for 6 h for positive control.](jcb1720395f03){#fig3}

SP-C^Δexon4^ expression increases susceptibility to viral-induced death
-----------------------------------------------------------------------

The increased expression of pro-apoptotic transcripts in SP-C^Δexon4^ cells ([Table I](#tbl1){ref-type="table"}) suggested that adapted cells may be more susceptible to secondary stress. Infection with respiratory syncytial virus (RSV) preceded the onset of ILD in several patients carrying the SP-C^L188Q^ mutation. To determine whether the expression of SP-C^Δexon4^ increased susceptibility to RSV, the clonal cells lines were infected at a multiplicity of infection (MOI) of 10 pfu/cell, and cell viability was assessed 24 h after infection. Although cell viability was minimally affected in SP-C^wt^ cells, as indicated by the low level of PI staining ([Fig. 4 a](#fig4){ref-type="fig"} \[b and f\]), the infection of cells expressing SP-C^Δexon4^ resulted in significant cell death ([Fig. 4 a](#fig4){ref-type="fig"} \[d and h\]). Western blot analysis demonstrated that SP-C^Δexon4^ protein accumulated in a manner directly correlated with the viral titer, whereas SP-C^wt^ protein levels were unaffected ([Fig. 4 b](#fig4){ref-type="fig"}). Several viruses, including adenovirus, influenza, and hepatitis B and C viruses, have been reported to induce ER stress/UPR pathways ([@bib22]; [@bib32]; [@bib33]; [@bib37]). To determine whether RSV activated the UPR in cells stably expressing SP-C, an UPR element luciferase reporter construct was transiently transfected into cells expressing SP-C^Δexon4^ or SP-C^wt^ before infection with RSV ([Fig. 4 c](#fig4){ref-type="fig"}). Baseline levels of luciferase activity were similar between the cell lines, which is consistent with the microarray data, indicating that the UPR was not activated in cells stably expressing SP-C^Δexon4^. However, luciferase activity was increased in both cell lines after RSV infection, and the effect was exacerbated in SP-C^Δexon4^ cells (2.5-fold increase in SP-C^wt^ vs. 4.4-fold increase in SP-C^Δexon4^; [Fig. 4 c](#fig4){ref-type="fig"}). Furthermore, RSV-induced cell death appeared to be independent of NF-κB, as NF-κB activity was sustained in both RSV-infected SP-C^Δexon4^ and SP-C^wt^ cells ([Fig. 4 d](#fig4){ref-type="fig"}). Consistent with this finding, UPR activity was not induced in SP-C^Δexon4^ cells when NF-κB activity was inhibited with SN50 ([Fig. 4 e](#fig4){ref-type="fig"}). Collectively, these data indicate that RSV infection was associated with accumulation of the mutant proprotein, pronounced activation of the UPR, and increased cell death independent of NF-κB activity.

![**SP-C^Δexon4^ increases susceptibility to RSV-induced cell death.** (a) Cells expressing SP-C^wt^ (panels a, b, e, and f) or SP-C^Δexon4^ (panels c, d, g, and h) were infected with RSV at 10 MOI (panels b, f, d, and h). Cells were stained with propidium iodide (PI) 24 hr after infection, and phase (panels a--d) or fluorescent (panels e--h) images were captured directly from the culture plate. Bars, 50 μm. (b) Immunoblot analysis of cells expressing SP-C^wt^ or SP-C^Δexon4^ after infection with 0.1, 1, or 10 MOI RSV for 24 h. Immunoblots were probed with an anti--proSP-C antibody or an anti-actin antibody (load-ing control). (c) Clonal cell lines expressing SP-C^wt^ or SP-C^Δexon4^ were transiently transfected with a reporter construct consisting of five UPR elements driv-ing luciferase (UPRE-Luc) and pRL-TK. Cells were infected with 5 MOI RSV 24 h after transfection, and luciferase activity was assessed 24 h after infection. Results are presented as means ± SD (error bars) of the ratio of firefly/renilla, expressed as relative luciferase units; each determination was performed in triplicate, and the experiment was repeated four times. (d) Cell lines were transiently transfected with pELAM-Luc and pRL-TK vectors and infected with RSV at indicated doses 24 h after transfection. (e) SP-C^Δexon4^ cells were transiently transfected with the UPRE-Luc and pRL-TK vectors. Cells were treated with SN50 or SN50~mut~ peptide 24 h after transfection at indicated doses. Cells were treated with 10 μg/ml tunicamycin for 12 h for posi-tive control. (d and e) Luciferase activity was assessed 48 h after transfection and normalized to renilla luciferase activity. Results are presented as means ± SD; each determination was performed in triplicate, and the experiment was repeated three times. Data indicate fold change relative to untreated control for each genotype. (c--e) \#, P \< 0.05 compared with SP-C^wt^ unRx; \*, P \< 0.05 compared with SP-C^Δexon4^ unRx; ♦, P \< 0.05 compared with RSV-infected SP-C^wt^.](jcb1720395f04){#fig4}

Proteasome function is decreased in RSV-infected SP-C^Δexon4^ cells
-------------------------------------------------------------------

Accumulation of mutant SP-C proprotein in RSV-infected SP-C^Δexon4^ cells suggested that proteasome function was inhibited. To assess the impact of RSV infection on proteasome activity, a proteasome reporter construct, pZsProSensor-1, was transiently transfected into the clonal cell lines. Cells were infected with 1--10 MOI of RSV and analyzed 24 h later by fluorescence microscopy and FACS analysis. Fluorescence in untreated SP-C^Δexon4^ cells (mean fluorescence intensity \[MFI\] = 305) was higher than that observed in untreated SP-C^wt^ cells (MFI = 156), indicating a modest inhibition of basal proteasome activity in the presence of the mutant proprotein ([Fig. 5](#fig5){ref-type="fig"}, a \[e\] vs. b \[e\]). Infection of SP-C^Δexon4^ cells with RSV resulted in a dose-dependent increase in fluorescence detected by microscopy and FACS ([Fig. 5 a](#fig5){ref-type="fig"} \[e--h\]). In contrast, fluorescence was not altered in SP-C^wt^ cells infected with RSV ([Fig. 5 b](#fig5){ref-type="fig"} \[e--h\]). Transfection efficiency was similar between the two cell lines, and the proteasome reporter was activated in SP-C^wt^ cells treated with MG-132 ([Fig. 5 c](#fig5){ref-type="fig"}). These results demonstrate that basal proteasome function is decreased in SP-C^Δexon4^ cells and that this perturbation is exacerbated during RSV infection.

![**Proteasome function is decreased in RSV-infected SP-C^Δexon4^ cells.** (a and b) The clonal cell lines expressing SP-C^Δexon4^ (a) or SP-C^wt^ (b) were transiently transfected with the proteasome sensor pZsProSensor-1 construct and infected with RSV at the indicated titers 24 h after transfection. Phase (top) and fluorescent (bottom) images were captured directly from the culture plate 24 h after infection. After image capture, cells were harvested and subjected to FACS analysis to determine MFI (reported in the top right corner of the bottom panels). (c) Clonal cells expressing SP-C^wt^ (panels a and c) or SP-C^Δexon4^ (panels b and d) were transfected with a plasmid encoding EGFP as a control for transfection efficiency (panels a and b) or with the pZsProSensor-1 vector in the presence of MG-132 (panels c and d) as a positive control. Cells were harvested and subjected to FACS analysis 24 h after transfection. Values for GFP+ cells and mean fluorescence intensity (MFI) are shown in the top right corner of each panel. Data is representative of three independent experiments. Bars, 50 μm.](jcb1720395f05){#fig5}

SP-C^Δexon4^ sensitizes cells to proteasome inhibition and is associated with accumulation of mutant proprotein and activation of XBP-1
---------------------------------------------------------------------------------------------------------------------------------------

To determine whether decreased proteasome function induced ER stress and activation of apoptosis independently of RSV infection, the clonal cell lines were treated with the proteasome inhibitor MG-132. The SP-C^Δexon4^ cell line was exquisitely sensitive to proteasome inhibition. The majority of cells retracted and detached from the plate after treatment with 250 nM MG-132 for 18 h, and a more pronounced effect was detected at the 500 nM of concentration ([Fig. 6 a](#fig6){ref-type="fig"} \[g and h\]). SP-C^wt^ cells were minimally affected by similar treatment ([Fig. 6 a](#fig6){ref-type="fig"} \[a--d\]). Cell viability was decreased ∼10% in SP-C^wt^ cells and 50% in SP-C^Δexon4^ cells treated with 500 nM MG-132 ([Fig. 6 b](#fig6){ref-type="fig"}).

![**SP-C^Δexon4^ sensitizes cells to proteasome inhibition.** (a) SP-C^wt^ and SP-C^Δexon4^ clonal cell lines were plated at equal cell densities and treated with the proteasome inhibitor MG-132 at the indicated concentrations. Phase photographs of the cells were captured directly from the culture plate 18 h after treatment. Bars, 50 μm. (b) MTS assay of cells treated as indicated in a. Results are presented as means ± SD (error bars); each determination was performed in triplicate, and the experiment was repeated three times. \*, P \< 0.05 compared with SP-C^Δexon4^ unRx; \#, P \< 0.05 compared with SP-C^wt^ unRx. (c) Immunoblots of whole cell lysates from clonal cell lines expressing SP-C^wt^ or SP-C^Δexon4^ after MG-132 treatment. Immunoblots were probed with antibodies against proSP-C antibody or actin (loading control). (d) Clonal cell lines expressing SP-C^wt^ or SP-C^Δexon4^ were cultured in the presence (+) or absence (−) of 500 nM MG-132 for 18 h. Total RNA was isolated from cells and subjected to RT-PCR analysis with primers spanning the intron of unspliced XBP-1 mRNA. XBP-1(u) denotes unspliced, inactive XBP-1; XBP-1(s) denotes spliced, active XBP-1; products were separated on a 4% agarose gel.](jcb1720395f06){#fig6}

To determine whether MG-132--induced cytotoxicity was associated with SP-C^Δexon4^ accumulation, immunoblot analysis was performed with a proSP-C antibody after MG-132 treatment. There was a dose-dependent increase in SP-C^Δexon4^ protein, whereas levels of the SP-C^wt^ protein were unaffected by MG-132 treatment ([Fig. 6 c](#fig6){ref-type="fig"}). Accumulation of unfolded proteins in the ER results in the activation of the IRE1--XBP-1 pathway (for review see [@bib11]). Active XBP-1 was not detected in SP-C^wt^ cells after MG-132 treatment; in contrast, robust activation of XBP-1 was detected in SP-C^Δexon4^ cells after proteasome inhibition ([Fig. 6 d](#fig6){ref-type="fig"}). Collectively, these results demonstrate that proteasome inhibition resulted in dose-dependent cytotoxicity associated with the accumulation of SP-C^Δexon4^ and the activation of XBP-1.

Accumulation of SP-C^Δexon4^ is associated with apoptosis
---------------------------------------------------------

To determine whether the accumulation of SP-C^Δexon4^ after proteasome inhibition was associated with apoptosis, cell lines were treated with MG-132 and stained with the fluorescent DNA-intercalating dye H33342 to assess nuclear architecture. Cells expressing SP-C^wt^ showed a diffuse, uniform staining of the nucleus typical of viable, healthy cells ([Fig. 7 a](#fig7){ref-type="fig"}, left panel and inset). Although the majority of cells expressing SP-C^Δexon4^ detached from the plate after MG-132 treatment and were excluded from this analysis, the cells that remained attached exhibited punctuate staining and nuclear condensation that is consistent with apoptosis ([Fig. 7 a](#fig7){ref-type="fig"}, right panel and inset). Furthermore, treatment of SP-C^Δexon4^--expressing HEK293 cells with MG-132 for 18 h resulted in the activation of caspase-3 ([Fig. 7 b](#fig7){ref-type="fig"}). Caspase-3 activation was not detected in SP-C^wt^ cells treated with MG-132, indicating that this event was specific for cells expressing mutant SP-C^Δexon4^ ([Fig. 7 b](#fig7){ref-type="fig"}). As previously reported, the expression of SP-C^Δexon4^ in the distal lung epithelium of transgenic mice resulted in cytotoxicity associated with lung dysmorphogenesis ([@bib1]). Immunohistochemistry was performed on fetal lung sections from a transgene-positive animal ([Fig. 7 d](#fig7){ref-type="fig"}, TG\#2) and a wild-type littermate control ([Fig. 7 d](#fig7){ref-type="fig"}, WT) with an antibody that detects the cleaved isoform of caspase-3. Robust staining for active caspase-3 was detected in sloughed epithelial cells in the distal airway and isolated intact epithelial cells in the transgenic animal, whereas lung epithelial cells in the wild-type animal were negative ([Fig. 7 d](#fig7){ref-type="fig"}). Together, these results demonstrate that the accumulation of SP-C^Δexon4^, induced by proteasome inhibition in vitro or overexpression in vivo, was associated with the activation of apoptotic pathways. In contrast, RSV infection resulted in specific, extensive death of SP-C^Δexon4^--expressing cells ([Fig. 4](#fig4){ref-type="fig"}) without evidence of caspase-3 activation ([Fig. 7 c](#fig7){ref-type="fig"}).

![**Accumulation of SP-C^Δexon4^ is associated with cell death.** (a) SP-C^wt^ (left) and SP-C^Δexon4^ (right) clonal cell lines were plated at equal cell density on poly-[d]{.smallcaps}-lysine--coated coverslips and treated with 500 nM MG-132. 18 h after treatment, the cells that remained attached to the coverslips were fixed, permeabilized, and stained with H33342 dye to visualize the nuclear architecture. Higher magnification of one representative cell is shown in the insets. Bars, 50 μm; (insets), 10 μm. (b) Clonal cell lines expressing SP-C^wt^ or SP-C^Δexon4^ were cultured in the presence or absence of MG-132 at the indicated concentrations, harvested 18 h after treatment, and subjected to immunoblot analysis with a caspase-3 antibody that detects both the precursor and cleaved isoforms. (c) Clonal cell lines expressing SP-C^wt^ or SP-C^Δexon4^ were infected with RSV at the indicated plaque-forming units s for 24 h. Cell lysates were harvested and subjected to immunoblot analysis with a caspase-3 antibody. SP-C^Δexon4^ cells were treated with MG-132 overnight for a positive control. (d) Immunohistochemistry for cleaved caspase-3 on lung sections from wild-type (WT) or transgenic mice (TG\#2) in which SP-C^Δexon4^ was expressed in the distal lung epithelium. Closed arrowheads represent cleaved caspase-3--positive cell debris, and open arrowheads represent red blood cells. Bars, 20 μm.](jcb1720395f07){#fig7}

Discussion
==========

The SP-C^Δexon4^ mutation was chosen for these experiments because of its link to ILD in human patients ([@bib28], [@bib29]), the severity of this mutation on the structure of the proprotein, and its association with cytotoxicity and lung dysmorphogenesis when expressed in transgenic mice ([@bib1]). Results of experiments performed in this study using stably transfected cells indicated that the SP-C^Δexon4^ cell line adapted to the constitutive expression of misfolded SP-C and that NF-κB played a pivotal role in the adaptive response. Infection of cells expressing SP-C^Δexon4^ with RSV resulted in enhanced cytotoxicity associated with decreased proteasome function, accumulation of the mutant proprotein, and cell death. Collectively, these results suggest that adaptation to chronic ER stress imposed by misfolded SP-C may promote resistance to ILD, whereas environmental insults, such as viral infection, may trigger the onset of disease in patients with mutations in *SFTPC*.

Although the effects of acute ER stress, imposed by xenotoxic agents such as thapsigargin and tunicamycin, are well established, little is known about the molecular pathways involved in adaptation to chronic ER stress imposed by a misfolded protein. The lack of a cytotoxic response coupled with the absence of ER stress induction in SP-C^Δexon4^ clonal cells suggested that these cells successfully adapted to the constitutive expression of misfolded SP-C. Several lines of evidence support this hypothesis. First, the level of SP-C mRNA in the SP-C^Δexon4^ cell line was comparable with that in the SP-C^wt^ cell line, thus excluding low expression of the mutant protein as a reason for the survival of SP-C^Δexon4^ cells. Second, in contrast to the wild-type protein, SP-C^Δexon4^ protein was barely detectable, indicating that the misfolded proprotein was recognized as terminally misfolded and rapidly degraded via the ERAD pathway. Furthermore, chronic expression of SP-C^Δexon4^ was associated with modestly reduced proteasome function that is consistent with near saturation of this degradative pathway. Third, components of the ER stress/UPR pathways were not transcriptionally up-regulated in the clonal SP-C^Δexon4^ cell line, which is in marked contrast to results in transiently transfected HEK293 cells ([@bib1]; [@bib24]). Fourth, chronic expression of SP-C^Δexon4^ was associated with differential expression of both pro- and anti-apoptotic genes, approximately half of which contained putative NF-κB--binding sites in their promoters. Lastly, the inhibition of NF-κB, which is known to promote cell survival in response to a variety of stresses, resulted in the death of SP-C^Δexon4^ cells. Collectively, these results are consistent with an NF-κB--dependent adaptive response to chronic ER stress imposed by the constitutive expression of SP-C^Δexon4^. Although the induction of other molecular pathways involved in cell survival may occur, the activation of NF-κB appears to be critical for survival in HEK293 cells that constitutively express SP-C^Δexon4^.

The role of NF-κB in the regulation of cytokine-stimulated proinflammatory gene expression is well established ([@bib21]). In this study, up-regulation of proinflammatory cytokines was not detected by microarray analyses; however, it is certainly possible that inflammation associated with lung injury and repair contributes to pathogenesis in vivo. NF-κB activity is also increased in response to the accumulation of transmembrane proteins in the ER, including the E3/19k protein of adenovirus ([@bib33]), middle human hepatitis B surface protein ([@bib22]), expression of major histocompatibility complex class 1 in the absence of β2-microglobin protein ([@bib33]), and p450 ([@bib36]). In addition, transient expression of the misfolded Z variant of α1-antitrypsin in CHO and HEK293 cells resulted in NF-κB activation associated with decreased levels of IκBα and IκBβ ([@bib19]). Activation of NF-κB in response to the accumulation of newly synthesized membrane or misfolded secretory proteins is referred to as the ER overload response. Constitutive activation of NF-κB promotes survival of a wide range of cells, including B cells, hepatic cells, and cancer cells, and is a major target for cancer therapy ([@bib18]). NF-κB promotes cell survival, in part, by activating anti-apoptotic genes, including members of the inhibitor of apoptosis family, TRAF1 and TRAF2, and the Bcl2 homologues Bfl-1/A1 and Bcl-X~l~ ([@bib18]). Recent studies using tunicamycin and thapsigargin as stressor agents demonstrated an association between ER stress--induced PERK activation, eIF2α phosphorylation, and NF-κB activation ([@bib17]; [@bib8]), effectively linking the UPR and the ER overload response. Although a definitive role for NF-κB activation in response to ER stress has not been established, it is thought to promote cell survival in this context.

Transient transfection of HEK293 cells with SP-C^Δexon4^ resulted in specific up-regulation of BiP, XBP-1, and HedJ1, which is consistent with the induction of UPR and ERAD to promote clearance of the misfolded protein and the alleviation of ER stress ([@bib1]; [@bib24]). In contrast, the constitutive expression of SP-C^Δexon4^ resulted in the differential expression of apoptosis-related genes with an apparent balance shifted toward NF-κB--dependent anti-apoptotic responses. Identification of environmental triggers that tip the balance toward apoptosis/cell death are clearly important for understanding disease pathogenesis in humans with *SFTPC* mutations. ILD is often associated with infection and/or inflammation ([@bib43]; [@bib26]). The marked variability in severity and age of onset of lung disease in the SP-C^L188Q^ pedigrees suggested that environmental factors might be involved in triggering the onset of ILD ([@bib39]; [@bib3]). Consistent with this hypothesis, five individuals in the SP- C^L188Q^ kindreds were diagnosed with viral infection before the manifestation of lung disease. Importantly, cells stably expressing SP-C^Δexon4^ were much more susceptible to viral-induced cell death, suggesting that infection may be an environmental trigger for ILD.

Although RSV infection in vivo is associated with epithelial cell damage and cellular desquamation, these cytopathic effects are primarily mediated by an augmented immune response initiated by the infected host cells rather than viral-induced cell death. In support of this hypothesis, mice depleted of CD4 and CD8 cells exhibited persistent viral replication without illness ([@bib10]). Furthermore, RSV infection of cultured airway epithelial cells (MOI of ∼20; i.e., twice the dose used in this study) did not result in cytopathology ([@bib48]). Consistent with these findings, HEK293 cells constitutively expressing SP-C^wt^ exhibited relatively little cell death in response to RSV infection ([Fig. 4 a](#fig4){ref-type="fig"}). In marked contrast, RSV infection of cells expressing SP-C^Δexon4^ resulted in extensive cell death associated with proteasome inhibition and accumulation of mutant proprotein. In vivo, injury of alveolar epithelial cells is an early event in progressive pulmonary fibrosis. Impaired reepithelialization leads to sustained proliferation/activation of interstitial fibroblasts and myofibroblasts, resulting in the accumulation of extracellular matrix and, ultimately, fibrosis ([@bib38]; [@bib27]). The increased susceptibility of some individuals to severe RSV pneumonia may further contribute to variability in the severity and onset of the disease ([@bib34]).

Although RSV infection was specifically cytotoxic for SP-C^Δexon4^--expressing cells, the molecular pathway leading to cell death is not clear. Cell death did not appear to be apoptosis dependent, as caspase-3 cleavage was undetectable in the RSV-infected cells ([Fig. 7 c](#fig7){ref-type="fig"}). RSV has been shown to inhibit apoptosis of cultured epithelial cells via the activation of EGF receptor--extracellular signal-regulated kinase and PI3K--AKT signaling pathways, thereby promoting self-replication ([@bib40]; [@bib23]). In this study, RSV-induced cytotoxicity was associated with proteasome dysfunction, accumulation of the mutant proprotein SP-C^Δexon4^, and pronounced activation of the UPR. Induction of ER stress and proteasome inhibition in RSV-infected SP-C^Δexon4^ cells may be related, in part, to forced synthesis of viral membrane proteins, including the F, G, and SH proteins. UPR activation was higher in SP-C^Δexon4^ cells than in SP-C^wt^ cells, suggesting that the production of RSV membrane proteins superimposed on the expression of misfolded SP-C^Δexon4^ protein may overwhelm the degradative capacity of the proteasome, leading to accumulation of cytotoxic forms of SP-C^Δexon4^ and subsequent cell death. Therefore, it is possible that proteasome dysfunction and accumulation of SP-C^Δexon4^ drives the cell down a nonapoptotic cell death pathway in the presence of RSV. In contrast, accumulation of SP-C^Δexon4^ in transgenic mice and MG-132--treated cells (i.e., in the absence of RSV infection) resulted in caspase-3 activation, which is typical of apoptosis ([Fig. 7 c](#fig7){ref-type="fig"}; [@bib1]).

Based on the findings of this study, the following model is proposed. SP-C^wt^ protein is correctly folded and exported from the ER, whereas SP-C^Δexon4^ is terminally misfolded and degraded by a proteasome-dependent pathway. Constitutive expression of terminally misfolded SP-C^Δexon4^ results in chronic ER stress and an NF-κB--dependent cytoprotective response. Superimposition of a secondary stress, such as RSV infection, on the constitutive expression of SP-C^Δexon4^ leads to proteasome dysfunction, accumulation of SP-C^Δexon4^, and cytotoxicity. Accumulation of SP-C^Δexon4^ and cytotoxicity may contribute to the pathogenesis of ILD associated with mutations in *SFTPC*.

Materials and methods
=====================

Reagents
--------

Recombinant TNFα protein was obtained from PeproTech. The MTS reduction assay kit and Dual-Luciferase Reporter Assay System were purchased from Promega; MTS reduction assays were performed in 96-well plates according to the manufacturer\'s protocol. MG-132, SN50, and control peptide (SN50~mut~) were obtained from EMD Biosciences.

SP-C cDNA constructs and generation of stably transfected cell lines
--------------------------------------------------------------------

Full-length human wild-type SP-C (SP-C^wt^) cDNA and SP-C^Δexon4^, generated as previously described ([@bib1]), were subcloned into pTRE2-Hyg (BD Biosciences) to generate SP-C^wt^/pTRE2-Hyg and SP-C^Δexon4^/pTRE2-Hyg. To generate stably transfected cell lines, HEK293 Tet-Off cells (CLONTECH Laboratories, Inc.) were transiently transfected with SP-C^wt^/pTRE2-Hyg or SP-C^Δexon4^/pTRE2-Hyg using LipofectAMINE 2000 (Invitrogen) in the presence of 250 μg/ml hygromycin B as the selection agent. Doxycycline was present in the media during the selection process to obtain regulatable lines (i.e., expression of SP-C^wt^ or SP-C^Δexon4^ was dependent on doxycycline withdrawal). However, all lines that were initially regulatable eventually reverted to constitutive expression of the transgene. Therefore, SP-C^wt^ or SP-C^Δexon4^ cells for this study were cultured in the absence of doxycycline and G418 (selection agent for the tTA cassette). Clonal colonies were isolated, amplified, and screened for integration of the transgene by RT-PCR using SP-C--specific primers and Western analyses using an antibody directed against the NH~2~-terminal peptide of proSP-C ([@bib1]).

RNA isolation, RT-PCR, and microarray analysis
----------------------------------------------

Total RNA for RT-PCR and real-time PCR analysis was isolated using the acidified guanidinium method ([@bib4]), treated with DNase I (DNA free; Ambion), and reverse transcribed into cDNA using SuperScript II Reverse Transcriptase (Invitrogen). Forward and reverse primer sequences for human XBP-1 are 5′-GGACTTAAGACAGCGCTTGG-3′ and 5′-TGAGAGGTGCTTCCTCGATT-3′. PCR reactions for XBP-1 were performed for 35 cycles, and products were separated on 4% agarose gels. Verification of microarray data for selected genes was performed by real-time PCR analysis with a SmartCycler (Cepheid) using reaction conditions as previously described ([@bib14]).

RNA samples for microarray analysis were prepared as previously described ([@bib6]) and hybridized to the GeneChip Human Genome U133 Set (HG-U133A and HG-U133B; Affymetrix, Inc.) according to the manufacturer\'s protocol. Affymetrix Microarray Suite 5.0 was used to scan and quantitate the gene chips under default scan settings. Normalization was performed using the Robust Multichip Average model ([@bib15],[@bib16]). Data were further analyzed using Significance Analysis Of Microarrays ([@bib41]) and Genespring 7.2 (Silicon Genetics). Detection of differential expression was performed using random permutation and Welch\'s approximate *t* test for mutant and control groups at P ≤ 0.01, false discovery rate ≤ 10%, a minimal of twofold changes in absolute ratio, and a minimum of two present calls by Affymetrix algorithm in three samples with the relative higher expression. Gene ontology analysis was performed using the database for annotation, visualization, and integrated discovery ([@bib9]). Potential protein--protein interactions were identified using PathwayAssist (Ariadne Genomics). NF-κB--binding sites (GGGACTTTCC) were scanned in −2-kb promoter regions of all differentially expressed genes from microarray analysis using MatInspector (Genomatix), allowing a maximum of one mismatch.

Cell culture and Western analysis
---------------------------------

HEK293 stable cell lines were propagated as previously described ([@bib1]). Cell lysate preparation, protein standardization, and Western analysis were performed as previously described ([@bib1]). Nuclear extracts were isolated as previously described ([@bib30]). Antibody sources are as follows: anti--proSP-C ([@bib44]), anti--caspase-3 (Cell Signaling), antihistone H2B (Imgenex), anti-p65 subunit of NF-κB (Santa Cruz Biotechnology, Inc.), and anti-actin ([@bib1]).

Confocal fluorescence
---------------------

Cells for confocal microscopy were prepared as previously described ([@bib5]). Primary antibodies included a polyclonal anti--proSP-C ([@bib1]), a monoclonal anti-LAMP1/CD107A (Research Diagnostics, Inc.), and a monoclonal anti-KDEL (StressGen Biotechnologies). Secondary antibodies included anti--rabbit FITC-conjugated and anti--mouse Texas red--conjugated secondary antibodies (Jackson ImmunoResearch Laboratories). Vectashield Hardset (Vector Laboratories) was used as the mounting medium. Fluorescence was visualized on a confocal microscope (LSM510; Carl Zeiss MicroImaging, Inc.) using FITC/Texas red filters and a 40× NA 1.3 objective.

Fluorescence and phase microscopy of live cells was performed on a microscope (LX70; Olympus) equipped with a UV lamp, FITC/Texas red filters, and a 20× NA 0.40 objective. Images were captured with a digital camera (MagnaFire; Optronics) using MagnaFire software (Optronics). For cell death assays, 2 μl of 1 mg/ml PI solution was added to live cells for 10 min at room temperature before visualization.

Flow cytometry
--------------

HEK293 cells were detached from the culture plate 24 h after RSV infection/transient transfection by treatment with trypsin/EDTA, washed once with PBS, and resuspended in FACS buffer consisting of PBS with 0.1% FBS and 0.05% sodium azide. Cell-associated fluorescence was measured on a FACScalibur flow cytometer using CellQuest software (BD Biosciences). For each sample, 20,000 events were acquired.

Immunohistochemistry
--------------------

Immunohistochemistry was performed on mouse fetal lung samples that were previously described ([@bib1]) using an antibody that detects the cleaved form of caspase-3 (R&D Systems) at a 1:5,000 dilution. Localization of antigen--antibody complexes was performed as previously described ([@bib1]).

RSV production and infection protocol
-------------------------------------

The A2 strain of RSV was amplified, purified, and quantitated in Hep2 as previously described ([@bib20]). Clonal cell lines were infected with RSV using a previously established protocol for adenoviral infection ([@bib1]). For studies in which proteasome activity was assessed after RSV infection, the proteasome sensor plasmid pZsProSensor-1 (CLONTECH Laboratories, Inc.) was transfected into the cells using LipofectAMINE 2000 24 h before RSV infection. The pZsProSensor-1 plasmid encodes a destabilized GFP consisting of amino acids 422--461 of the degradation domain of mouse ornithine decarboxylase protein fused to the COOH terminus of the naturally occurring reef coral *Zoanthus* species protein (ZsGreen). This fusion protein is rapidly degraded by the proteasome in an ubiquitin-independent manner.

Luciferase constructs and assays
--------------------------------

The NF-κB--dependent ELAM-1 promoter-driven firefly luciferase plasmid (pELAM-luc) was obtained from M.J. Fenton (University of Maryland, Baltimore, MA). The p5xATF6GL3 plasmid (also known as the UPR element luciferase reporter) was obtained from R. Prywes (Columbia University, New York, NY). The IκB SR expression plasmid was obtained from R. Hay (University of St. Andrews, St. Andrews, Scotland). The pRL-TK plasmid was purchased from Promega. 400 ng of firefly luciferase construct was cotransfected with 50 ng pRL-TK using LipofectAMINE 2000 (Invitrogen). Cells were harvested 48 h after transfection, and luciferase activity was quantified using the Dual-Luciferase Assay system in a Berthold multitube luminometer. Data are plotted as the ratio of firefly/renilla activity to correct for transfection efficiency among samples.

Statistics
----------

Data were analyzed with InStat version 3.0 (GraphPad Software). Values are presented as means ± SD. Multiple comparisons were made by analysis of variance between groups using the Tukey-Kramer multiple comparisons test, and paired samples were analyzed by *t* tests. In both cases, statistical significance was defined as P \< 0.05 or less.

Online supplemental material
----------------------------

Fig. S1 is a model of functional associations between differentially expressed genes in SP-C^Δexon4^ cells associated with apoptosis using PathwayAssist software. Table SI lists descriptive information of apoptosis-associated genes from the model in Fig. S1. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200508016/DC1>.
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